Skip to main content
Clinical Trials/NCT03028181
NCT03028181
Completed
Not Applicable

The Evaluation of Pro/Antioxidative Profile and Diagnostic Parameters in the Patients With Acute Pancreatitis

Wroclaw Medical University0 sites34 target enrollmentStarted: January 2014Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Wroclaw Medical University
Enrollment
34
Primary Endpoint
Pro-inflammatory effect of tobacco smoke exposure measured by hsCRP concentration in the blood of patients with acute pancreatitis

Overview

Brief Summary

The study aims to assess and analyze some selected antioxidants and laboratory parameters during hospitalization of the patients with acute pancreatitis. It will allow to better understanding of the mechanisms of disease and the development of better diagnostic, treatment and monitoring.

It is an observational diagnostic study and does not involve any additional administration of medicinal substances, modification of treatment or dropping the use of routine methods of treatment of a disease. The study procedure includes detailed personal medical history as separate document like as a routine medical interview, and three times taking a small amount of venous blood (together about 15 ml), in the first, third, and seventh day of hospitalization (in the case of longer hospital treatment).

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • The patients were classified into the group of patients with acute pancreatitis (AP) due to clinical symptoms (acute onset of a persistent, severe, epigastric pain with tenderness on palpation on physical examination), personal interview and clinical method used in the diagnosis of pancreatitis - laboratory tests (elevation in serum lipase or amylase to three times or greater than the upper limit of normal) and characteristic findings of acute pancreatitis on imaging (contrast-enhanced computed tomography (CT), magnetic resonance imaging (MRI) or transabdominal ultrasonography). In patients with characteristic abdominal pain and elevation in serum lipase or amylase to three times or greater than the upper limit of normal, no imaging was required to establish the diagnosis of acute pancreatitis. In patients with abdominal pain that was not characteristic for acute pancreatitis or serum amylase or lipase levels that were less than three times the upper limit of normal, or in whom the diagnosis was uncertain, the investigators performed abdominal imaging with a contrast-enhanced abdominal CT scan to establish the diagnosis of acute pancreatitis and to exclude other causes of acute abdominal pain. In patients with severe contrast allergy or renal failure, the investigators performed an abdominal MRI without gadolinium.
  • The volunteers classified as healthy based on the research conducted by clinicians of primary medical care (control group)

Exclusion Criteria

  • other accompanied diseases than acute pancreatitis (the patients groups)
  • Individuals of the control group with diagnosed disease as well as alcohol and drugs abusers

Outcomes

Primary Outcomes

Pro-inflammatory effect of tobacco smoke exposure measured by hsCRP concentration in the blood of patients with acute pancreatitis

Time Frame: 3 weeks

Pro-inflammatory effect of tobacco smoke exposure measured by Interleukin-6 concentration in the blood of patients with acute pancreatitis

Time Frame: 2 weeks

Secondary Outcomes

  • The estimation of antioxidant status measured by the activities of antioxidant enzymes in the blood(12 months)
  • The estimation of antioxidant status measured by small molecular antioxidants concentration in the blood(3 months)
  • The estimation of prooxidant status measured by the concentration of lipids peroxidation products in the blood(2 months)
  • The estimation of prooxidant status measured by the concentration of advanced oxidation protein products in the blood(1 months)

Investigators

Sponsor
Wroclaw Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Milena Ściskalska

Principal Investigator

Wroclaw Medical University

Similar Trials